Indaptus Therapeutics Inc (INDP) concluded trading on Thursday at a closing price of $0.40, with 11.78 million shares of worth about $4.71 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -60.00% during that period and on May 29, 2025 the price saw a gain of about 25.71%. Currently the company’s common shares owned by public are about 16.03M shares, out of which, 12.90M shares are available for trading.
Stock saw a price change of 5.26% in past 5 days and over the past one month there was a price change of -14.89%. Year-to-date (YTD), INDP shares are showing a performance of -52.50% which decreased to -82.91% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.31 but also hit the highest price of $3.10 during that period. The average intraday trading volume for Indaptus Therapeutics Inc shares is 446.62K. The stock is currently trading -2.23% below its 20-day simple moving average (SMA20), while that difference is down -17.76% for SMA50 and it goes to -58.53% lower than SMA200.
Indaptus Therapeutics Inc (NASDAQ: INDP) currently have 16.03M outstanding shares and institutions hold larger chunk of about 13.08% of that.
The stock has a current market capitalization of $6.41M and its 3Y-monthly beta is at 1.55. It has posted earnings per share of -$1.49 in the same period. It has Quick Ratio of 1.90 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for INDP, volatility over the week remained 15.22% while standing at 7.64% over the month.
Stock’s fiscal year EPS is expected to rise by 16.15% while it is estimated to increase by 33.33% in next year. EPS is likely to shrink at an annualized rate of 18.55% for next 5-years, compared to annual growth of 57.27% made by the stock over the past 5-years.
